Sign in

CIK 0001235912 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Ticker
CVRX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
7634162850
Business address
9201 WEST BROADWAY AVENUE, SUITE 650, MINNEAPOLIS, MN, 55445
Former names
CVRX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-02 VERRASTRO PAUL CHIEF MKTG & STRAT OFFICER Grant or award · Stock Option (right to buy) +32,000 32,000
2024-02-02 Yared Nadim CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (right to buy) +22,050 22,050
2024-01-29 Yared Nadim CHIEF EXECUTIVE OFFICER Option exercise +4,055 $0.24 $961 24,310
2024-01-29 Yared Nadim CHIEF EXECUTIVE OFFICER Option exercise +1,945 $0.24 $461 26,255
2024-01-29 Yared Nadim CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (right to buy) −4,055 0
2024-01-29 Yared Nadim CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (right to buy) −1,945 29,092
2023-12-28 SLATTERY JOSEPH P Director Option exercise +224 $0.24 $53 20,419
2023-12-28 SLATTERY JOSEPH P Director Option exercise +1,456 $0.24 $345 21,875
2023-12-28 SLATTERY JOSEPH P Director Option exercise +174 $1.19 $206 22,049
2023-12-28 SLATTERY JOSEPH P Director Option exercise +96 $3.96 $380 22,145
2023-12-28 SLATTERY JOSEPH P Director Option exercise · Stock Option (right to buy) −224 0
2023-12-28 SLATTERY JOSEPH P Director Option exercise · Stock Option (right to buy) −1,456 0
2023-12-28 SLATTERY JOSEPH P Director Option exercise · Stock Option (right to buy) −174 0
2023-12-28 SLATTERY JOSEPH P Director Option exercise · Stock Option (right to buy) −96 7,590
2023-12-14 Behbahani Ali Director Option exercise +316 $0.24 $75 316
2023-12-14 Behbahani Ali Director Option exercise · Stock Option (right to buy) −316 0
2023-10-16 Galle Liz VP OF GLOBAL CLINICAL RESEARCH Option exercise +778 $0.24 $184 778
2023-10-16 Galle Liz VP OF GLOBAL CLINICAL RESEARCH Option exercise · Stock Option (right to buy) −778 0
2023-09-18 OASHEIM JARED CHIEF FINANCIAL OFFICER Option exercise +527 $0.24 $125 10,112
2023-09-18 OASHEIM JARED CHIEF FINANCIAL OFFICER Option exercise +5,335 $3.96 $21K 15,447

Page 8 of 22 · 422 trades